We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for pralsetinib (Roche Products Pty Limited)
Active ingredients
pralsetinib
Sponsor
Date of review outcome
Lapse date
Type
Provisional determination
Therapeutic area
Oncology